Merit Medical Systems Inc

Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain

Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent

Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance